DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Cohen H, Doré CJ, Clawson S. , et al; RAPS Trial Protocol Collaborators.
Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
Lupus 2015;
24 (10) 1087-1094
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.